Developer docs
API playgroundTry for free, no card

Search company profiles

BlueSkeye AI

Full company profile

uuid00024zv

Namestring
BlueSkeye AI
Legal namestring
BLUESKEYE AI Ltd
Websiteurl
blueskeye.com
Company typeenum
Private
Founded yearint
2019
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNottingham, United Kingdom
HQ citystring
Nottingham
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
facial behaviour analysis, emotional intelligence software, automotive driver monitoring, social robotics SDK, mental health biomarkers
Industry2 codes
PRIMARYHDAAAEAI
Autonomous Driving & ADAS Perception
SECONDARYHLACAFAM
AI/Analytics for RPM (Risk Stratification, Alerts, Predictive)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
NAICS code2 codes
  • Computer Systems Design and Related Services54151
  • Home Health Care Services621610
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
AI Emotional Intelligence Software (Face & Voice Behaviour Analysis)
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Automotive SDK Licensing / OEM Software Supply
TypeLicensing Royalties
Description

B-Automotive SDK licensed to global automotive OEMs and Tier 1 suppliers as a production-grade software component integrated into ADAS and Intelligent Cockpit vehicle programmes. Revenue is generated through design-win fees, NRE (non-recurring engineering) charges, and per-unit or annual licensing fees tied to vehicle production programmes. The May 2026 production contract with a global OEM represents the first major commercial validation of this model.

blueskeye.com
2Social Robotics SDK Licensing
TypeLicensing Royalties
Description

B-Social SDK licensed to social robotics companies (e.g., Enchanted Tools) for integration into social and assistive robot platforms. Revenue model based on per-unit licensing or platform licensing agreements with robotics OEMs.

blueskeye.com
3Healthcare / Clinical Software Licensing
TypeSubscription Recurring
Description

Technology licensed for clinical applications including mental health triage, clinical trials biomarker tools, and remote consultations. The TrueBlue app, used in NHS-affiliated clinical studies, represents a potential subscription or per-user licensing model for healthcare providers.

blueskeye.com
4Consumer Research / UX Research SDK
TypeSubscription Recurring
Description

SDK for passive, granular emotional response measurement in consumer product testing, UX research, and media effectiveness studies. Likely commercialised as a SaaS subscription or usage-based licensing model.

blueskeye.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

BlueSkeye AI builds on-edge face and voice analysis software that decodes social, emotional, and medical behaviour in real time (sub-130ms). Its portfolio includes the B-Automotive SDK for in-cabin driver/occupant monitoring and ADAS, the B-Social / B-Social 3 SDK for social and assistive robotics, and the TrueBlue App for perinatal mental health monitoring. The technology is licensed to automotive OEMs and Tier 1 suppliers, robotics OEMs, healthcare providers, and consumer/UX research organisations, with all inference running on-device and no biometric data sent to the cloud.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Detects emotional changes in less than 130ms — real-time inference with no cloud latency
+4 more records
Product overview1 text field

BlueSkeye AI offers a portfolio of sector-specific software products built on a unified face and voice analysis platform. The core technology processes face and voice data entirely on-edge (no cloud transmission) to detect emotional states in under 130ms. The product family includes B-Automotive SDK for automotive driver/occupant monitoring and ADAS applications, B-Social/B-Social 3 SDK for social robotics applications, and the TrueBlue App for maternal mental health monitoring in healthcare. Core capabilities include face detection/tracking, eye gaze tracking, facial action unit analysis (46 units at 15fps), expressed emotion detection, visual voice activity tracking, multi-person processing, and re-identification. These modules can be deployed individually or combined depending on industry requirements across automotive, health, robotics, and consumer research sectors.

Product and service4 records
1B-Automotive SDK
CategoryAutomotive In-Cabin Sensing Software
Description

Software-only SDK delivering real-time on-edge social and emotional intelligence for automotive ADAS and Intelligent Cockpit programmes. Processes multimodal face and voice data to provide granular, continuous insights into driver and occupant expressed emotion, mood, drowsiness, and mental state, integrating with existing in-cabin NIR cameras on ARM, x86, Samsung Exynos, and NVIDIA Jetson automotive-grade chipsets.

2B-Social SDK
CategorySocial Robotics Software
Description

SDK enabling social and assistive robots to perceive and interpret human social and emotional signals. Includes facial muscle analysis, user identification, oculometry, head pose estimation, and expressed emotion analysis for empathetic human-robot interaction. Addresses the cocktail-party problem (counting people, identifying speakers, addressees, topics, and engagement levels in group conversations).

3B-Social 3 SDK
CategorySocial Robotics Software
Description

Advanced SDK for social robotics delivering facial muscle analysis, user identification, oculometry, head pose estimation, and expressed emotion analysis to enable robots to operate acceptably in shared human environments such as care, retail, and hospitality.

4TrueBlue App
CategoryDigital Mental Health Software
Description

Smartphone application for perinatal maternal mental health monitoring that uses BlueSkeye's on-device face and voice analysis with a virtual human avatar (Kira) to capture objective, real-time measurements of mood for early detection and severity monitoring of depression and anxiety. Validated with Nottinghamshire Healthcare NHS Foundation Trust and the University of Nottingham.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-08
Description

Blueskeye AI and Enchanted Tools are partnering to refine socially intelligent interaction in social and assistive robots, beginning with Enchanted Tools' Mirokaï platform. Blueskeye AI's B-Social 3 SDK — including facial muscle analysis, user identification, oculometry, head pose estimation, and expressed emotion analysis — is being integrated to enable more empathetic, socially coherent human-robot interactions. Enchanted Tools develops people-facing social and assistive robots for healthcare (including ICM radiotherapy support for children) and senior living environments.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partner in the TrueBlue Clinical Study, a collaborative initiative delivered with Nottinghamshire Healthcare NHS Foundation Trust. Blueskeye's face and voice analysis technology is used within the TrueBlue smartphone app to capture objective, real-time measurements of mood through subtle facial and vocal analysis. The study aims to prove the app is a safe and effective tool for early detection and severity monitoring of perinatal depression. The team won 1st Place Poster Presentation at RCOG Perinatal Mental Health Conference (March 2026).

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical partner in the TrueBlue Clinical Study alongside the University of Nottingham. The Trust provides clinical oversight and NHS pathway validation for the Blueskeye AI-powered TrueBlue app, which uses a virtual human avatar named Kira to interact with mothers and mothers-to-be while capturing objective mood biomarkers through face and voice analysis. Dr Neil Nixon, Clinical Associate Professor in Adult Mood Disorder at the University of Nottingham/Nottinghamshire Healthcare NHS FT, is quoted as supporting the technology's potential to move beyond traditional clinical assessment.

4DATAcc by DiMe (Digital Medicine Society)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Blueskeye AI is listed as one of over 20 industry, advocacy, and research partners contributing to DATAcc by DiMe's first set of digital measures specifically designed for common mental health disorders. The seven measures include speech/language changes and facial/gaze features as clinical trial endpoints. The resource was commissioned by Wellcome and advances outcomes-based approaches in mental health treatment.

aijourn.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Swedish publicly-listed driver monitoring system specialist with multi-OEM production contracts across Europe, US, and Japan. Direct competitor to Blueskeye's B-Automotive SDK, operating in the same Euro NCAP 2026-driven DMS/OMS market with a much larger installed base and longer revenue history.

TypeDirect peer
Description

Australian-listed DMS company with both aftermarket (Guardian) and embedded OEM business lines shipping into production vehicles. Competes head-to-head with Blueskeye in driver and occupant monitoring, with similar emotion/attention AI capabilities.

3Cipia
TypeDirect peer
Description

Israeli AI computer vision company focused exclusively on in-cabin sensing (DMS/OMS). Comparable product offering to Blueskeye's B-Automotive SDK and a direct competitor in OEM and Tier 1 sales processes globally.

TypeDirect peer
Description

Emotion AI pioneer acquired by Xperi, providing facial expression analysis for automotive cabin experience and media analytics. Overlaps directly with Blueskeye's expressed-emotion, facial action unit, and multi-person analysis capabilities across automotive and consumer research verticals.

TypeEmerging player
Description

US-based in-cabin sensing AI company supplying Tier 1s with emotion, gaze, and occupant monitoring. Comparable technology stack and similar Tier 1/OEM go-to-market motion, though with a US rather than UK geographic anchor.

TypeBroad incumbent
Description

Global Tier 1 automotive supplier with broad ADAS and cockpit portfolios. As a large incumbent, Aptiv could be either a Blueskeye customer (integrating the SDK into its cabin platform) or a competitor building similar in-house emotion AI capabilities.

TypeBroad incumbent
Description

Major automotive Tier 1 with an established DMS/OMS product line and integrated cabin sensing offerings. Represents both potential customer and competitor depending on whether Blueskeye's SDK is integrated or displaced by Continental's in-house stack.

TypeEmerging player
Description

US-based vocal biomarker company detecting mental and physical health conditions from short voice samples. Comparable to Blueskeye's TrueBlue mental health monitoring concept, though Sonde focuses on voice-only biomarkers rather than multimodal face+voice.

TypeEmerging player
Description

Clinical-grade voice biomarker AI for anxiety and depression detection used in clinical workflows. Closest comparable to Blueskeye's NHS-affiliated TrueBlue programme from a clinical-deployment and mental-health-triage standpoint.

TypeEmerging player
Description

US-based emotion AI company offering voice and facial expression analysis APIs for product/research use cases. Comparable to Blueskeye's emotion-detection and consumer-research SDK offerings, with broader developer-market distribution.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature11 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

BlueSkeye AI

AI Emotional Intelligence Software (Face & Voice Behaviour Analysis)blueskeye.com

BlueSkeye AI firmographics

Firmographics
Name
BlueSkeye AI
Legal name
BLUESKEYE AI Ltd
Website
https://blueskeye.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

BlueSkeye AI industry classification

Industry
Product category
AI Emotional Intelligence Software (Face & Voice Behaviour Analysis)
NAICS
Computer Systems Design and Related Services (54151), Home Health Care Services (621610)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro industry
PRIMARYHDAAAEAI
Autonomous Driving & ADAS Perception
SECONDARYHLACAFAM
AI/Analytics for RPM (Risk Stratification, Alerts, Predictive)
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms

Keywords

  • Facial behaviour analysis
  • Emotional intelligence software
  • Automotive driver monitoring
  • Social robotics SDK
  • Mental health biomarkers

Where BlueSkeye AI is headquartered

Location

Headquarters

HQ city
Nottingham
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

BlueSkeye AI business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Automotive SDK Licensing / OEM Software Supply: B-Automotive SDK licensed to global automotive OEMs and Tier 1 suppliers as a production-grade software component integrated into ADAS and Intelligent Cockpit vehicle programmes. Revenue is generated through design-win fees, NRE (non-recurring engineering) charges, and per-unit or annual licensing fees tied to vehicle production programmes. The May 2026 production contract with a global OEM represents the first major commercial validation of this model.
  2. Social Robotics SDK Licensing: B-Social SDK licensed to social robotics companies (e.g., Enchanted Tools) for integration into social and assistive robot platforms. Revenue model based on per-unit licensing or platform licensing agreements with robotics OEMs.
  3. Healthcare / Clinical Software Licensing: Technology licensed for clinical applications including mental health triage, clinical trials biomarker tools, and remote consultations. The TrueBlue app, used in NHS-affiliated clinical studies, represents a potential subscription or per-user licensing model for healthcare providers.
  4. Consumer Research / UX Research SDK: SDK for passive, granular emotional response measurement in consumer product testing, UX research, and media effectiveness studies. Likely commercialised as a SaaS subscription or usage-based licensing model.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

BlueSkeye AI product offering

Product offering

Core offering

BlueSkeye AI builds on-edge face and voice analysis software that decodes social, emotional, and medical behaviour in real time (sub-130ms). Its portfolio includes the B-Automotive SDK for in-cabin driver/occupant monitoring and ADAS, the B-Social / B-Social 3 SDK for social and assistive robotics, and the TrueBlue App for perinatal mental health monitoring. The technology is licensed to automotive OEMs and Tier 1 suppliers, robotics OEMs, healthcare providers, and consumer/UX research organisations, with all inference running on-device and no biometric data sent to the cloud.

Product overview

BlueSkeye AI offers a portfolio of sector-specific software products built on a unified face and voice analysis platform. The core technology processes face and voice data entirely on-edge (no cloud transmission) to detect emotional states in under 130ms. The product family includes B-Automotive SDK for automotive driver/occupant monitoring and ADAS applications, B-Social/B-Social 3 SDK for social robotics applications, and the TrueBlue App for maternal mental health monitoring in healthcare. Core capabilities include face detection/tracking, eye gaze tracking, facial action unit analysis (46 units at 15fps), expressed emotion detection, visual voice activity tracking, multi-person processing, and re-identification. These modules can be deployed individually or combined depending on industry requirements across automotive, health, robotics, and consumer research sectors.

Differentiator

Problem solved

Functional benefit

Products and services

  • B-Automotive SDK Software-only SDK delivering real-time on-edge social and emotional intelligence for automotive ADAS and Intelligent Cockpit programmes. Processes multimodal face and voice data to provide granular, continuous insights into driver and occupant expressed emotion, mood, drowsiness, and mental state, integrating with existing in-cabin NIR cameras on ARM, x86, Samsung Exynos, and NVIDIA Jetson automotive-grade chipsets.
  • B-Social SDK SDK enabling social and assistive robots to perceive and interpret human social and emotional signals. Includes facial muscle analysis, user identification, oculometry, head pose estimation, and expressed emotion analysis for empathetic human-robot interaction. Addresses the cocktail-party problem (counting people, identifying speakers, addressees, topics, and engagement levels in group conversations).
  • B-Social 3 SDK Advanced SDK for social robotics delivering facial muscle analysis, user identification, oculometry, head pose estimation, and expressed emotion analysis to enable robots to operate acceptably in shared human environments such as care, retail, and hospitality.
  • TrueBlue App Smartphone application for perinatal maternal mental health monitoring that uses BlueSkeye's on-device face and voice analysis with a virtual human avatar (Kira) to capture objective, real-time measurements of mood for early detection and severity monitoring of depression and anxiety. Validated with Nottinghamshire Healthcare NHS Foundation Trust and the University of Nottingham.

Quantifiable outcome

  • Detects emotional changes in less than 130ms — real-time inference with no cloud latency
  • +4 more outcomes

Companies that use BlueSkeye AI

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

BlueSkeye AI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature11 records

BlueSkeye AI partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and minor.

  • Enchanted ToolscoreStrategic or Co-development Partner · 8 January 2026Blueskeye AI and Enchanted Tools are partnering to refine socially intelligent interaction in social and assistive robots, beginning with Enchanted Tools' Mirokaï platform. Blueskeye AI's B-Social 3 SDK — including facial muscle analysis, user identification, oculometry, head pose estimation, and expressed emotion analysis — is being integrated to enable more empathetic, socially coherent human-robot interactions. Enchanted Tools develops people-facing social and assistive robots for healthcare (including ICM radiotherapy support for children) and senior living environments.
  • University of NottinghamcoreStrategic or Co-development PartnerResearch partner in the TrueBlue Clinical Study, a collaborative initiative delivered with Nottinghamshire Healthcare NHS Foundation Trust. Blueskeye's face and voice analysis technology is used within the TrueBlue smartphone app to capture objective, real-time measurements of mood through subtle facial and vocal analysis. The study aims to prove the app is a safe and effective tool for early detection and severity monitoring of perinatal depression. The team won 1st Place Poster Presentation at RCOG Perinatal Mental Health Conference (March 2026).
  • Nottinghamshire Healthcare NHS Foundation TrustcoreStrategic or Co-development PartnerClinical partner in the TrueBlue Clinical Study alongside the University of Nottingham. The Trust provides clinical oversight and NHS pathway validation for the Blueskeye AI-powered TrueBlue app, which uses a virtual human avatar named Kira to interact with mothers and mothers-to-be while capturing objective mood biomarkers through face and voice analysis. Dr Neil Nixon, Clinical Associate Professor in Adult Mood Disorder at the University of Nottingham/Nottinghamshire Healthcare NHS FT, is quoted as supporting the technology's potential to move beyond traditional clinical assessment.
  • DATAcc by DiMe (Digital Medicine Society)minorStrategic or Co-development PartnerBlueskeye AI is listed as one of over 20 industry, advocacy, and research partners contributing to DATAcc by DiMe's first set of digital measures specifically designed for common mental health disorders. The seven measures include speech/language changes and facial/gaze features as clinical trial endpoints. The resource was commissioned by Wellcome and advances outcomes-based approaches in mental health treatment.

Scale indicators6 records

Recent moves6 records

Expansion highlights7 records

BlueSkeye AI competitors and assessment

Company assessment

Direct peers

  • Smart Eye: Swedish publicly-listed driver monitoring system specialist with multi-OEM production contracts across Europe, US, and Japan. Direct competitor to Blueskeye's B-Automotive SDK, operating in the same Euro NCAP 2026-driven DMS/OMS market with a much larger installed base and longer revenue history.
  • Seeing Machines: Australian-listed DMS company with both aftermarket (Guardian) and embedded OEM business lines shipping into production vehicles. Competes head-to-head with Blueskeye in driver and occupant monitoring, with similar emotion/attention AI capabilities.
  • Cipia: Israeli AI computer vision company focused exclusively on in-cabin sensing (DMS/OMS). Comparable product offering to Blueskeye's B-Automotive SDK and a direct competitor in OEM and Tier 1 sales processes globally.
  • Affectiva (Xperi): Emotion AI pioneer acquired by Xperi, providing facial expression analysis for automotive cabin experience and media analytics. Overlaps directly with Blueskeye's expressed-emotion, facial action unit, and multi-person analysis capabilities across automotive and consumer research verticals.

Emerging players

  • Eyeris: US-based in-cabin sensing AI company supplying Tier 1s with emotion, gaze, and occupant monitoring. Comparable technology stack and similar Tier 1/OEM go-to-market motion, though with a US rather than UK geographic anchor.
  • Sonde Health: US-based vocal biomarker company detecting mental and physical health conditions from short voice samples. Comparable to Blueskeye's TrueBlue mental health monitoring concept, though Sonde focuses on voice-only biomarkers rather than multimodal face+voice.
  • Ellipsis Health: Clinical-grade voice biomarker AI for anxiety and depression detection used in clinical workflows. Closest comparable to Blueskeye's NHS-affiliated TrueBlue programme from a clinical-deployment and mental-health-triage standpoint.
  • Hume AI: US-based emotion AI company offering voice and facial expression analysis APIs for product/research use cases. Comparable to Blueskeye's emotion-detection and consumer-research SDK offerings, with broader developer-market distribution.

Broad incumbents

  • Aptiv: Global Tier 1 automotive supplier with broad ADAS and cockpit portfolios. As a large incumbent, Aptiv could be either a Blueskeye customer (integrating the SDK into its cabin platform) or a competitor building similar in-house emotion AI capabilities.
  • Continental: Major automotive Tier 1 with an established DMS/OMS product line and integrated cabin sensing offerings. Represents both potential customer and competitor depending on whether Blueskeye's SDK is integrated or displaced by Continental's in-house stack.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

BlueSkeye AI social profiles

Digital presence

BlueSkeye AI compliance and trust

Trust signal

Compliance4 records

BlueSkeye AI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

BlueSkeye AI leadership team

Management profile

Number of profiles

Profiles3 records

BlueSkeye AI funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

BlueSkeye AI M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BlueSkeye AI

What does BlueSkeye AI do?

BlueSkeye AI builds on-edge face and voice analysis software that decodes social, emotional, and medical behaviour in real time (sub-130ms). Its portfolio includes the B-Automotive SDK for in-cabin driver/occupant monitoring and ADAS, the B-Social / B-Social 3 SDK for social and assistive robotics, and the TrueBlue App for perinatal mental health monitoring. The technology is licensed to automotive OEMs and Tier 1 suppliers, robotics OEMs, healthcare providers, and consumer/UX research organisations, with all inference running on-device and no biometric data sent to the cloud.

Is BlueSkeye AI a public or private company?

BlueSkeye AI is a private company. It is classified as venture growth investor backed and is currently operating.

When was BlueSkeye AI founded?

BlueSkeye AI was founded in 2019. It employs 11 to 50 people.

Where is BlueSkeye AI based?

BlueSkeye AI is headquartered in Nottingham, United Kingdom, in the Europe region.

How does BlueSkeye AI make money?

Four revenue lines are on record. Automotive SDK Licensing / OEM Software Supply is the primary driver. The others are social Robotics SDK Licensing, healthcare / Clinical Software Licensing and consumer Research / UX Research SDK.

Who are BlueSkeye AI's main competitors?

Direct peers on record are Smart Eye, Seeing Machines, Cipia and Affectiva (Xperi). Emerging players are Eyeris, Sonde Health, Ellipsis Health and Hume AI. Broad incumbents are Aptiv and Continental.

Does BlueSkeye AI have an API?

No public API is recorded for BlueSkeye AI.

What industry is BlueSkeye AI in?

BlueSkeye AI's product category is AI Emotional Intelligence Software (Face & Voice Behaviour Analysis). Its primary akta.pro industry code is HDAAAEAI, Autonomous Driving & ADAS Perception, with a secondary code of HLACAFAM, AI/Analytics for RPM (Risk Stratification, Alerts, Predictive). Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireBlueSkeye AI Launches Groundbreaking Technology Using Mobile Devices to Analyze Facial Expressions and Vocal Behavior for Clinical Use at CES 2024BlueSkeye AI is launching its Health Foundation Platform at CES 2024, using mobile devices to analyze facial expressions and vocal behavior for clinical use. The platform can detect emotions, fatigue, pain, and early signs of conditions like autism, Parkinson's, and Alzheimer's, and is already in a UK NHS trial for perinatal depression.BBCHow AI is revolutionising mental health diagnosesBlueSkeye AI, a UK start-up, uses facial-tracking technology to diagnose mental health conditions, with its perinatal depression app Avocado having 200,000 users. The company is in clinical trials with the NHS and plans to expand into Japan, aided by the UK's CPTPP accession.EU-StartupsAddressing the mental health crisis with digital tech – Introducing BlueSkeye AIUK-based startup BlueSkeye AI has raised approximately €3.8 million in funding led by XTX Ventures to expand its AI-driven mental health diagnosis and care services. The company, a spin-out from the University of Nottingham, plans to use the capital to accelerate product development and establish a physical presence in the North-West of England.BusinessCloudBlueSkeye AI raises £3.4m to transform mental health diagnosesBlueSkeye AI raised £3.4 million in funding led by XTX Ventures, with participation from Foresight Group, Praetura Ventures, the University of Nottingham, and high-net-worth individuals. The healthtech startup will use the funds to expand its face and voice analysis technology for mental health diagnosis and automotive safety, and will open a physical presence in the North West of England.FinSMEsBlueSkeye AI Raises £3.4M in FundingBlueSkeye AI, a Nottingham-based healthtech firm, raised £3.4M in funding led by XTX Ventures. The company will use the funds to expand across clinical and non-clinical health markets and establish a physical presence in North-West England. It develops proprietary face and voice analysis for mental health diagnoses and vehicle safety.BusinessCloudExperts claim smartphone camera can spot depressionUniversity of Nottingham experts developed camera-based technology to detect changes in behavior and facial expression linked to stress and depression. The technology, developed by BlueSkeye AI, aims to provide a quicker route to diagnosing mental health problems and could be available on mobile phones. The University is supporting the spin-out through Nottingham Technology Ventures.